Understanding mitochondrial disease and goals for its treatment
| Autor: | David Codier, Estelle Codier |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
medicine.medical_specialty
Mutation Mitochondrial Diseases business.industry Mitochondrial disease Emotions Disease progression Treatment goals Disease Mitochondrion Bioinformatics medicine.disease_cause medicine.disease Nursing care Quality of life (healthcare) Disease Progression Quality of Life medicine Humans Psychiatry business General Nursing |
| Zdroj: | British Journal of Nursing. 23:254-258 |
| ISSN: | 2052-2819 0966-0461 |
| DOI: | 10.12968/bjon.2014.23.5.254 |
| Popis: | Mitochondrial disease is a progressive, debilitating, incurable illness that results from mutation of genes that regulate mitochondrial function. The disease can manifest in utero or at birth, during childhood, or have a delayed onset in adulthood. Mitochondrial disease can be transmitted as a genetically carried mutation or develop as a spontaneous genetic mutation later in life. As a multisystem disease with a highly variable clinical presentation, mitochondrial disease can present as ‘any disease with any symptoms at any age’. Consequently, all patients with progressive, unexplained multisystem illness should be evaluated for mitochondrial disease. Treatment goals include slowing of disease progression and maximising quality of life. There is no cure for this illness. Effective interdisciplinary care includes energy management, nutritional support, physical therapy and emotional support for the patient and their family. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|